We conducted a pan-cancer analysis of SMARCA1 based on the TCGA and GTEx databases and investigated the underlying molecular mechanisms of SMARCA1 in carcinogenesis, clinical prognosis and targeted therapy of various carcinomas. The gene discussed is SMARCA1; the disease is cancer.